{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "St. Jude Children's Research Hospital"
  ],
  "article_type": "PUBLISHAHEADOFPRINT",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "name": "M. A. Brimble"
    },
    {
      "name": "S. Tan"
    },
    {
      "name": "S. Buddle"
    },
    {
      "name": "L.-A. K. Brown"
    },
    {
      "name": "J. Breuer"
    },
    {
      "affs": [
        0
      ],
      "name": "J. C. Crawford"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/df5jjs8eaf43a.bib",
  "cited_by": 0,
  "doi": "10.64898/2026.09.10.26362787",
  "fulltext_url": "https://www.medrxiv.org/content/10.64898/2026.09.10.26362787v1.full",
  "id": "df5jjs8eaf43a",
  "issns": [],
  "landing_url": "https://www.medrxiv.org/content/10.64898/2026.09.10.26362787v1",
  "language": null,
  "licence": "LicenseRef-all-rights-reserved",
  "licence_label": "All rights reserved",
  "licence_source": "article",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "medrxiv",
      "genetic and genomic medicine"
    ],
    [
      "openalex",
      "1311|Virus-based gene therapy research"
    ]
  ],
  "openalex": "W7212514333",
  "pdf_url": "https://www.medrxiv.org/content/10.64898/2026.09.10.26362787v1.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-09-10",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/df5jjs8eaf43a.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:18:31Z",
      "native_id": "10.64898/2026.09.10.26362787",
      "source": "medrxiv",
      "url": "https://www.medrxiv.org/content/10.64898/2026.09.10.26362787v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "medrxiv:genetic and genomic medicine",
      "subfield": "human-genetics"
    }
  ],
  "title": "P5 promoter-mediated incorporation explains REP/CAP manufacturing contaminants in patient liver after rAAV gene therapy",
  "title_text": "P5 promoter-mediated incorporation explains REP/CAP manufacturing contaminants in patient liver after rAAV gene therapy",
  "type": "preprint",
  "updated_at": "2026-10-30T12:18:31Z",
  "url": "https://research.draconitic.com/paper/df5jjs8eaf43a",
  "venue": "medRxiv",
  "versions": []
}